Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO Italy 2022 | An insight into the pathogenesis of AML

Francesco Buccisano • 24 Oct 2022
SOHO Italy 2022
Acute Myeloid Leukemia Leukemia

Francesco Buccisano, MD, University of Rome Tor Vergata, Rome, Italy, briefly discusses the pathogenesis of acute myeloid leukemia (AML), highlighting the complexity of this disease, and challenges involved in the management of patients with AML. This interview took place at The 4th Society of Hematologic Oncology (SOHO) Italy Annual Conference, held in Rome, Italy.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Explore the AML Channel banner with headshots of Naval Daver, Eunice Wang, and Thomas Cluzeau

More from Francesco Buccisano

Incorporating MRD assessment into clinical decision-making in AML: recent ELN guideline update
2:19
Incorporating MRD assessment into clinical decision-making in AML: recent ELN guideline update
Francesco Buccisano • 23 Mar 2026
The EBMT recommendations for MRD-guided interventions in patients with AML undergoing alloSCT
1:42
The EBMT recommendations for MRD-guided interventions in patients with AML undergoing alloSCT
Francesco Buccisano • 23 Mar 2026
Revisiting the WHO and ICC 2022 scores for AML and MDS: addressing differences between the systems
2:08
Revisiting the WHO and ICC 2022 scores for AML and MDS: addressing differences between the systems
Francesco Buccisano • 23 Mar 2026
Adapting MRD monitoring to each patient with AML based on their disease profile
1:32
Adapting MRD monitoring to each patient with AML based on their disease profile
Francesco Buccisano • 31 Mar 2025

Related Videos

Is there a role for CAR T-cell therapy in the treatment pathway for CLL?
1:21
Is there a role for CAR T-cell therapy in the treatment pathway for CLL?
Marco Ruella • 16 Oct 2026
Access challenges to diagnosis and treatment for patients with CLL in resource-restricted countries
1:45
Access challenges to diagnosis and treatment for patients with CLL in resource-restricted countries
Celso Arrais • 17 Oct 2026
Insights into the current CLL treatment algorithm and emerging research directions
1:51
Insights into the current CLL treatment algorithm and emerging research directions
Matthew Davids • 17 Oct 2026
How has the harmonization of genomic profiling in Sweden impacted patient access to CLL diagnostics?
1:21
How has the harmonization of genomic profiling in Sweden impacted patient access to CLL diagnostics?
Richard Rosenquist • 17 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals